eNeuras Therapeutics Obtains $2,226,421 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a897b587-4f2b-49f5-9a52-9bac529ce58c&Preview=1 - Date
4/15/2013 - Company Name
eNeuras Therapeutics - Mailing Address
240 N. Wolfe Rd. Sunnyvale, CA 94085 - Company Description
eNeuras Therapeutics, Inc, a privately held medical technology company, is pioneering the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. - Website
http://www.eneuras.com - Transaction Type
Venture Equity - Transaction Amount
$2,226,421 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
